373 related articles for article (PubMed ID: 19678928)
1. Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.
Sriwilaijaroen N; Wilairat P; Hiramatsu H; Takahashi T; Suzuki T; Ito M; Ito Y; Tashiro M; Suzuki Y
Virol J; 2009 Aug; 6():124. PubMed ID: 19678928
[TBL] [Abstract][Full Text] [Related]
2. Outbreak of highly pathogenic avian influenza in Japan and anti-influenza virus activity of povidone-iodine products.
Ito H; Ito T; Hikida M; Yashiro J; Otsuka A; Kida H; Otsuki K
Dermatology; 2006; 212 Suppl 1():115-8. PubMed ID: 16490988
[TBL] [Abstract][Full Text] [Related]
3. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
4. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Ikematsu H; Kawai N
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
[TBL] [Abstract][Full Text] [Related]
5. A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.
Panaampon J; Ngaosuwankul N; Suptawiwat O; Noisumdaeng P; Sangsiriwut K; Siridechadilok B; Lerdsamran H; Auewarakul P; Pooruk P; Puthavathana P
PLoS One; 2012; 7(5):e36318. PubMed ID: 22563489
[TBL] [Abstract][Full Text] [Related]
6. Use of lentiviral pseudotypes as an alternative to reassortant or Triton X-100-treated wild-type Influenza viruses in the neuraminidase inhibition enzyme-linked lectin assay.
Biuso F; Palladino L; Manenti A; Stanzani V; Lapini G; Gao J; Couzens L; Eichelberger MC; Montomoli E
Influenza Other Respir Viruses; 2019 Sep; 13(5):504-516. PubMed ID: 31411006
[TBL] [Abstract][Full Text] [Related]
7. NA proteins of influenza A viruses H1N1/2009, H5N1, and H9N2 show differential effects on infection initiation, virus release, and cell-cell fusion.
Chen Q; Huang S; Chen J; Zhang S; Chen Z
PLoS One; 2013; 8(1):e54334. PubMed ID: 23349854
[TBL] [Abstract][Full Text] [Related]
8. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.
Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J
Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430
[TBL] [Abstract][Full Text] [Related]
9. Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.
Changsom D; Lerdsamran H; Wiriyarat W; Chakritbudsabong W; Siridechadilok B; Prasertsopon J; Noisumdaeng P; Masamae W; Puthavathana P
PLoS One; 2016; 11(4):e0153183. PubMed ID: 27054879
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015.
Tewawong N; Marathe BM; Poovorawan Y; Vongpunsawad S; Webby RJ; Govorkova EA
PLoS One; 2018; 13(1):e0190877. PubMed ID: 29324781
[TBL] [Abstract][Full Text] [Related]
11. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
Leneva IA; Roberts N; Govorkova EA; Goloubeva OG; Webster RG
Antiviral Res; 2000 Nov; 48(2):101-15. PubMed ID: 11114412
[TBL] [Abstract][Full Text] [Related]
12. Homoisoflavonoids from Caesalpinia sappan displaying viral neuraminidases inhibition.
Jeong HJ; Kim YM; Kim JH; Kim JY; Park JY; Park SJ; Ryu YB; Lee WS
Biol Pharm Bull; 2012; 35(5):786-90. PubMed ID: 22687418
[TBL] [Abstract][Full Text] [Related]
13. H9N2 Influenza Virus Infections in Human Cells Require a Balance between Neuraminidase Sialidase Activity and Hemagglutinin Receptor Affinity.
Arai Y; Elgendy EM; Daidoji T; Ibrahim MS; Ono T; Sriwilaijaroen N; Suzuki Y; Nakaya T; Matsumoto K; Watanabe Y
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641475
[TBL] [Abstract][Full Text] [Related]
14. Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.
Tivane A; Daniels R; Nguenha N; Machalele L; Nacoto A; Pale M; Mateonane E; Mavale S; Chilundo J; Muteto D; Salência J; Albati F; Gudo E; Mussá T; McCauley J
PLoS One; 2018; 13(7):e0201248. PubMed ID: 30048502
[TBL] [Abstract][Full Text] [Related]
15. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
16. Mapping the interaction sites of human and avian influenza A viruses and complement factor H.
Rabeeah I; Billington E; Nal B; Sadeyen JR; Pathan AA; Iqbal M; Temperton NJ; Zipfel PF; Skerka C; Kishore U; Shelton H
Front Immunol; 2024; 15():1352022. PubMed ID: 38698856
[TBL] [Abstract][Full Text] [Related]
17. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2015 Mar; 90(12):109-20. PubMed ID: 25796641
[No Abstract] [Full Text] [Related]
18. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL
J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411
[TBL] [Abstract][Full Text] [Related]
19. A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein.
Hooper KA; Bloom JD
J Virol; 2013 Dec; 87(23):12531-40. PubMed ID: 24027333
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the binding and cleavage characteristics of N1 neuraminidases from avian, seasonal, and pandemic influenza viruses using saturation transfer difference nuclear magnetic resonance.
Garcia JM; Lai JC; Haselhorst T; Choy KT; Yen HL; Peiris JS; von Itzstein M; Nicholls JM
Influenza Other Respir Viruses; 2014 Mar; 8(2):235-42. PubMed ID: 24118862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
